Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

SBRI Healthcare Awards £12.7M Funding to 44 Companies

Published: Thursday, April 10, 2014
Last Updated: Thursday, April 10, 2014
Bookmark and Share
Largest number of companies to date will benefit under the SBRI Healthcare programme to develop innovative solutions towards better health outcomes.

SBRI Healthcare, an NHS England funded initiative to develop innovative products and services that address unmet health needs, announced a record 44 companies will share £12.7million development funding in the latest rounds of the scheme. The award is across three competitions each representing a distinct product/service development phase – feasibility, prototype development and validation in NHS settings. 

With successful projects selected on their potential value to the health service, patient benefit and the opportunity to back thriving businesses, SBRI Healthcare looked for companies specifically focused on driving towards “Better Patient Experience” and “Improving Patient Outcomes” across eight categories; Cancer, Cardiovascular, COPD, Diabetes, End of life, Mental Health, Patient Safety and Research Tools. This latest round of competitions also included the first example in the country of phase 3 SBRI funding, with eight companies awarded up to £1m each to evaluate and validate their SBRI Healthcare backed products in NHS settings.

Karen Livingstone, Director of SBRI Healthcare, commented: “SBRI Healthcare has seen steady growth since it was developed back in 2007. This last year has seen a rapid expansion, both in terms of the number of companies involved and the level of funding. This funding growth is testament to the programme’s success and reaffirms NHS England’s commitment to healthcare innovation and evidencing the contribution of the NHS to the wider economy. Through SBRI Healthcare we are seeing exciting new technologies and products that will bring a sea change in patient care.  The programme is also building successful business in the life science sector – vital for UK growth. 

John Eaglesham, Chief Executive of Advanced Digital Institute (ADI) (www.adi-uk.com), said “This award is fantastic news for ADI, for our NHS partners, and for the people living with chronic pain. We are really excited at the opportunity the award gives to demonstrate the benefits of a new, digitally supported, approach to chronic pain across the pathway.” ADI has been awarded Phase 2 funding to develop a suite of self-help digital products to support people with chronic pain, enabling both patient and practitioner to have a balanced step-wise process to self-assess, self-manage, and self-monitor changes in pain via for example, a mobile phone app. The company will be working closely with clinical experts in Leeds to test their solutions.

Chief Executive of PolyPhotonix (www.polyphotonix.com), Richard Kirk said “The SBRI Healthcare funding means that PolyPhotonix can undertake a crucial development programme to accelerate adoption of a treatment that could save the NHS £1bn and will result in the care pathway development being shortened by a number of years. Without this support we simply would not have been able to undertake the work required”. Using Phase 3 funding to evaluate the care pathway for NHS adoption, PolyPhotonix is developing a Sleep Mask for the prevention and treatment of Diabetic Retinopathy, which is a home-based, primary care, non-invasive, monitored therapy, and will be delivered at a fraction of the current treatment cost.

Funding for SBRI Healthcare has been secured from NHS England. The programme is directed by the Eastern Academic Health Science Network (EAHSN) on behalf of NHS England. Health Enterprise East is the management partner and supports the EAHSN to handle the applications, assessments and delivery against contracts.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Improving Outcomes for Lung Cancer and Diabetic Patients
Novel technologies have been developed with support from SBRI Healthcare funding.
Wednesday, November 18, 2015
Small Businesses Receive £1.25 Million SBRI Healthcare Funding
Latest award to support the development of 14 innovative new technologies in priority healthcare areas.
Tuesday, May 12, 2015
SBRI Healthcare to Award Further £2.5 M in Latest Competition
Funding will be awarded to develop innovative solutions that improve outcomes for patients and deliver value to the health service.
Monday, May 19, 2014
Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Review of the Analysis of Haemoglobin A1c for Diabetes Diagnostics
This paper aims to clarify methods, units, quality requirements, reference and cutoff limits for hemoglobin A1c (HbA1c) and ratio of blood glucose/HbA1c on the basis of the results from Finnish quality control surveys by comparing them to the literature.
Colon Cancer Blocked in Mice
Case Western Reserve University Researchers block common type of colon cancer tumour in mice, laying groundwork for human clinical trial.
Drug - Gene 'One-Two' Punch Against Cancer
Researchers identify gene-drug combinations that, together, target and kill cancer cells while not targeting healthy cells.
Liquid Biopsies Treating Ovarian Cancer
Researchers have discovered a promising monitor and treat recurrence of ovarian cancer. Detecting cancer long before tumours reappear.
72% Rise in Metastatic Prostate Cancer
Over the 2003-2013 period metastatic cancer has increased by an average of 72%, this could be caused by lax screening, more aggressive disease or both.
Lab-Tested Diagnosis Needed When Treating Persistent Diarrhea
New PCR multiplex method makes lab testing more effective.
Biomarker for Multiple Sclerosis Detection Discovered
Winthrop-University Hospital researchers discover biomarker for multiple sclerosis detection.
Scientists Link Bipolar Disorder to Unexpected Brain Region
Researchers from The Scripps Research Institute have found that gene within the brain’s striatum could be linked to biopolar disorder.
Liquid Biopsies: DNA Size Matters
Study finds circulating tumour DNA can be distinguished from healthy DNA through fragment size identification.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!